Research
Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months
-
* Corresponding author: John PA Lusingu jpalusingu@yahoo.co.uk
Malaria Journal 2009, 8:163 doi:10.1186/1475-2875-8-163
No comments have yet been made on this article.